Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes.
Kahan
B D
BD
Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas, USA.
Napoli
K L
KL
Podbielski
J
J
Hussein
I
I
Katz
S H
SH
Van Buren
C T
CT
D000208:Acute Disease; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006084:Graft Rejection / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use; D012372:ROC Curve; D012044:Regression Analysis; D020123:Sirolimus / Q000097:blood* / Q000627:therapeutic use
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone; D020123:Sirolimus